FDA Approves the First New Schizophrenia Drug in Decades
Developed by Karuna Therapeutics, which was subsequently acquired by Bristol Myers Squibb, the drug works in an entirely ...
Daily Jang57m
FDA approves first new schizophrenia treatment approach in decades
The US Food and Drug Administration has greenlit a new drug, marketed as Cobenfy, for oral use to treat schizophrenia in ...
US FDA approves Sanofi-Regeneron's Dupixent for 'smoker's lung'
Sanofi recorded 10.72 billion euros ($11.94 billion) in sales for Dupixent in 2023, which includes Regeneron's share.
Sanofi/Regeneron’s Dupixent set to dominate COPD biologics market following FDA approval
Dupixent has gained positive opinions from KOLs due to the positive data presented from the asset’s two Phase III clinical ...
New schizophrenia drug ‘could change the lives of millions of people’
The US Food and Drug Administration has approved Cobenfy, which is owned by pharmaceutical firm Bristol Myers Squibb.
Do not feed this to your pets: Dog, cat food recalled after illnesses
The U.S. Food and Drug Administration warns customers to not feed their pets certain lots of these pet food brands as they ...
AbbVie Seeks Accelerated FDA OK of Teliso-V in Non-Small Cell Lung Cancer
AbbVie on Friday said the application covers telisotuzumab vedotin, or teliso-V, in adults with previously treated, locally advanced or metastatic epidermal growth factor receptor wild type, ...
First novel Schizophrenia treatment in decades gains FDA approval
The first new kind of treatment for schizophrenia patients in decades is arriving. The U.S. Food and Drug Administration ...
mashviral20s
New Schizophrenia Drug Gets FDA Green Light — First of Its Kind in Over 30 years
The U. S. Food and Drug Administration (FDA) has signed off on Cobenfy, the first revolutionary treatment for schizophrenia ...
Fertility treatments might increase heart defect risk in babies
Babies conceived through assisted reproductive technology are more likely to be born with a major heart defect, new research ...
PharmiWeb2m
Dupixent approved in the US as the first-ever biologic medicine for patients with COPD
Dupixent is indicated for the approximately 300,000 adults in the US with inadequately controlled COPD and an eosinophilic phenotypeFollowing recent approvals in the EU and China, the US approval is ...
Top Stock Movers Now: Wynn Resorts, AT&T, Newmont, and More
U.S. equities were mixed at midday as the Federal Reserve's favored measure of inflation was lower than anticipated.